Y Moride, RA Hegele, A Langer, R McPherson, DB Miller, S Rinfret. Clinical and public health assessment of benefits and risks of statins in primary prevention of coronary events: Resolved and unresolved issues. Can J Cardiol 2008;24(4):293-300

Can J Cardiol. 2008 Aug;24(8):615. doi: 10.1016/s0828-282x(08)70662-7.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Attitude of Health Personnel*
  • Clinical Trials as Topic
  • Coronary Artery Disease / prevention & control*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Public Opinion*
  • Risk Assessment

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors